Autophagy-deficient Kupffer cells promote tumorigenesis by enhancing mtROS-NF-κB-IL1α/β-dependent inflammation and fibrosis during the preneoplastic stage of hepatocarcinogenesis. (1st March 2017)
- Record Type:
- Journal Article
- Title:
- Autophagy-deficient Kupffer cells promote tumorigenesis by enhancing mtROS-NF-κB-IL1α/β-dependent inflammation and fibrosis during the preneoplastic stage of hepatocarcinogenesis. (1st March 2017)
- Main Title:
- Autophagy-deficient Kupffer cells promote tumorigenesis by enhancing mtROS-NF-κB-IL1α/β-dependent inflammation and fibrosis during the preneoplastic stage of hepatocarcinogenesis
- Authors:
- Sun, Kai
Xu, Lingyun
Jing, Yingying
Han, Zhipeng
Chen, Xiaojing
Cai, Chenlei
Zhao, Peipei
Zhao, Xue
Yang, Liqun
Wei, Lixin - Abstract:
- Abstract: As a cellular degradation mechanism, autophagy exerts crucial and complicated effects on HCC development. Liver non-parenchymal cells, including hepatic resident macrophage Kupffer cells, also play important roles in this process. However, most associated studies have focused on the influence of the autophagy level in hepatic cells and HCC cells, but not liver non-parenchymal cells. Based on our previous study, we confirmed that Atg5 silence in the liver during the preneoplastic stage facilitated liver fibrosis, inflammation and, ultimately, tumorigenesis. We further found that autophagy deficiency promotes the production of inflammatory and fibrogenic factors in macrophages. Moreover, Kupffer cell depletion rescued the tumor-promoting effect of autophagy deficiency during the preneoplastic stage. In autophagy-deficient macrophages, mitochondrial ROS mediated inflammation- and fibrosis-promoting effects by increasing IL1α/β production via enhancing NF-κB-associated pathways. Both blocking of mitochondrial ROS and blocking the IL1 receptor stopped the promotion of fibrosis, inflammation and tumorigenesis resulting from Atg5 knockdown during the preneoplastic stage. In conclusion, autophagy-deficient Kupffer cells promote liver fibrosis, inflammation and, finally, hepatocarcinogenesis during the preneoplastic stage by enhancing mitochondrial ROS- NF-κB-IL1α/β pathways. Highlights: Atg5 defect at preneoplastic stage reduces inflammation, fibrosis and tumorigenesis.Abstract: As a cellular degradation mechanism, autophagy exerts crucial and complicated effects on HCC development. Liver non-parenchymal cells, including hepatic resident macrophage Kupffer cells, also play important roles in this process. However, most associated studies have focused on the influence of the autophagy level in hepatic cells and HCC cells, but not liver non-parenchymal cells. Based on our previous study, we confirmed that Atg5 silence in the liver during the preneoplastic stage facilitated liver fibrosis, inflammation and, ultimately, tumorigenesis. We further found that autophagy deficiency promotes the production of inflammatory and fibrogenic factors in macrophages. Moreover, Kupffer cell depletion rescued the tumor-promoting effect of autophagy deficiency during the preneoplastic stage. In autophagy-deficient macrophages, mitochondrial ROS mediated inflammation- and fibrosis-promoting effects by increasing IL1α/β production via enhancing NF-κB-associated pathways. Both blocking of mitochondrial ROS and blocking the IL1 receptor stopped the promotion of fibrosis, inflammation and tumorigenesis resulting from Atg5 knockdown during the preneoplastic stage. In conclusion, autophagy-deficient Kupffer cells promote liver fibrosis, inflammation and, finally, hepatocarcinogenesis during the preneoplastic stage by enhancing mitochondrial ROS- NF-κB-IL1α/β pathways. Highlights: Atg5 defect at preneoplastic stage reduces inflammation, fibrosis and tumorigenesis. Autophagy defect in KCs assist in the tumor-promoting effects of autophagy deficiency. Autophagy-deficient KCs facilitate inflammation and fibrosis by increasing IL1α/β. IL1α/β secretion relies on mtROS and NF-κB in autophagy-deficient macrophages. Both anakinra and mito-Q reverse the tumor-promoting effects of Atg5 inhibition. … (more)
- Is Part Of:
- Cancer letters. Volume 388(2017)
- Journal:
- Cancer letters
- Issue:
- Volume 388(2017)
- Issue Display:
- Volume 388, Issue 2017 (2017)
- Year:
- 2017
- Volume:
- 388
- Issue:
- 2017
- Issue Sort Value:
- 2017-0388-2017-0000
- Page Start:
- 198
- Page End:
- 207
- Publication Date:
- 2017-03-01
- Subjects:
- Autophagy -- Kupffer cells -- Inflammation -- Fibrosis -- IL1
HCC Hepatocellular carcinoma -- CQ Chloroquine -- ROS reactive oxygen species -- KCs Kupffer cells -- HSCs hepatic stellate cells -- FBS fetal bovine serum -- DMEM Dulbecco's modified Eagle's medium -- LPS lipopolysaccharide -- NAC N-Acetyl-l-cysteine -- mito-Q mitoquinone -- dTPP Decyltriphenylphosphonium bromide -- EtBr ethidium bromide -- shRNA short hairpin RNA -- siRNA small interfering RNA -- Scr scramble -- CM conditioned medium -- SD Sprague Dawley -- DEN N-diethylnitrosamine -- GdCl3 Gadolinium(III) chloride -- i.p. intraperitoneal -- H&E hematoxylin and eosin -- qPCR Quantitative-PCR -- ELISA Enzyme-Linked Immunosorbent Assay -- MTDR MitoTracker® Deep Red FM
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03043835/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.canlet.2016.12.004 ↗
- Languages:
- English
- ISSNs:
- 0304-3835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.485000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2530.xml